(Q46617027)

23 December 2017

title

Polydrug use, cannabis, and psychosis-like symptoms (English)

1 reference

23 December 2017

1 reference

Nicholas T Van Dam

1

0 references

author name string

Mitch Earleywine

series ordinal

2

1 reference

23 December 2017

Greg DiGiacomo

series ordinal

3

1 reference

23 December 2017

publication date

1 August 2008

1 reference

23 December 2017

published in

Human Psychopharmacology

1 reference

23 December 2017

volume

23

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

475-485

1 reference

23 December 2017

Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean?

cites work

1 reference

Risk of schizophrenia in character disordered patients

21 January 2018

1 reference

The SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria

21 January 2018

1 reference

Three-factor model of schizotypal personality: invariance across culture, gender, religious affiliation, family adversity, and psychopathology.

21 January 2018

1 reference

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

21 January 2018

1 reference

7 January 2021

Causal association between cannabis and psychosis: examination of the evidence

1 reference

7 January 2021

The relationship between cannabis use and schizotypal symptoms.

1 reference

7 January 2021

Cannabis-induced psychosis-like experiences are associated with high schizotypy.

1 reference

7 January 2021

The earth is round (p < .05).

1 reference

7 January 2021

Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function

1 reference

7 January 2021

Altered states: the clinical effects of Ecstasy.

1 reference

7 January 2021

Cannabis use correlates with schizotypal personality traits in healthy students

1 reference

7 January 2021

Psychomotor stimulant addiction: a neural systems perspective.

1 reference

7 January 2021

Endocannabinoid signaling system and brain reward: emphasis on dopamine

1 reference

7 January 2021

Is cannabis use psychotogenic?

1 reference

7 January 2021

Cannabis use and psychotic disorders: an update

1 reference

7 January 2021

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

1 reference

7 January 2021

Psychiatric effects of cannabis

1 reference

7 January 2021

Cannabis and psychosis

1 reference

7 January 2021

Relationship between cannabis use, schizotypal traits, and cognitive function in healthy subjects

1 reference

7 January 2021

Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms

1 reference

7 January 2021

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

1 reference

7 January 2021

Earliest recollections of childhood: a demographic analysis

1 reference

7 January 2021

The incidence of schizotypy among cannabis and alcohol users.

1 reference

7 January 2021

Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity

1 reference

7 January 2021

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems

1 reference

7 January 2021

Schizotypal personality: neurodevelopmental and psychosocial trajectories

1 reference

7 January 2021

1 reference

7 January 2021

Collecting behavioural data using the world wide web: considerations for researchers

1 reference

7 January 2021

Drug addiction: bad habits add up.

1 reference

7 January 2021

Differential effects of Ecstasy and cannabis on self-reports of memory ability: a web-based study.

1 reference

7 January 2021

Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.

1 reference

7 January 2021

Symptoms of schizotypy precede cannabis use

1 reference

7 January 2021

Comorbidity between substance use disorders and psychiatric conditions

1 reference

7 January 2021

Cannabis use is associated with schizotypy and attentional disinhibition.

1 reference

7 January 2021

Cannabis use and the risk of later schizophrenia: a review

1 reference

7 January 2021

Cannabis use and psychosis: a longitudinal population-based study.

1 reference

7 January 2021

Cannabis use and dimensions of psychosis in a nonclinical population of female subjects

1 reference

7 January 2021

What do we know about drug addiction?

1 reference

7 January 2021

The multidimensionality of self-report schizotypy in a psychiatric population: an analysis using multidimensional Rasch models

1 reference

7 January 2021

Does the Schizotypal Personality Questionnaire reflect the biological-genetic vulnerability to schizophrenia?

1 reference

7 January 2021

Survey of substance use among high school students in Taipei: web-based questionnaire versus paper-and-pencil questionnaire

1 reference

7 January 2021

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group

1 reference

7 January 2021

Cannabis and psychosis – Authors' reply

1 reference

7 January 2021

Cannabis and psychosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.950

1 reference

23 December 2017

1 reference

23 December 2017